Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2019 4
2020 4
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma.
Salcher S, Spoden G, Hagenbuchner J, Führer S, Kaserer T, Tollinger M, Huber-Cantonati P, Gruber T, Schuster D, Gust R, Zwierzina H, Müller T, Kiechl-Kohlendorfer U, Ausserlechner MJ, Obexer P. Salcher S, et al. Oncogene. 2020 Jan;39(5):1080-1097. doi: 10.1038/s41388-019-1044-7. Epub 2019 Oct 7. Oncogene. 2020. PMID: 31591479 Free PMC article.
The Biology of Classic Hairy Cell Leukemia.
Bohn JP, Salcher S, Pircher A, Untergasser G, Wolf D. Bohn JP, et al. Among authors: salcher s. Int J Mol Sci. 2021 Jul 21;22(15):7780. doi: 10.3390/ijms22157780. Int J Mol Sci. 2021. PMID: 34360545 Free PMC article. Review.
Deregulated glutamate to pro-collagen conversion is associated with adverse outcome in lung cancer and may be targeted by renin-angiotensin-aldosterone system (RAS) inhibition.
Kocher F, Tymoszuk P, Amann A, Sprung S, Salcher S, Daum S, Haybaeck J, Rinnerthaler G, Huemer F, Kauffmann-Guerrero D, Tufman A, Seeber A, Wolf D, Pircher A. Kocher F, et al. Among authors: salcher s. Lung Cancer. 2021 Sep;159:84-95. doi: 10.1016/j.lungcan.2021.06.020. Epub 2021 Jul 16. Lung Cancer. 2021. PMID: 34315093 Free article.
12 results